跳至主要内容
临床试验/CTRI/2025/10/096197
CTRI/2025/10/096197尚未招募不适用

Association of serum SIRT-1 level and PCSK9 gene polymorphism in coronary artery disease with metabolic syndrome

Maulana Azad Medical college1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2026年10月10日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
60
试验地点
1
主要终点
association of serum SIRT1 and metabolic syndrome in patients of coronary artery disease

研究概览

简要总结

The present study will be conducted with the primary objective of discovering association of serum SIRT1 and PCSK9 gene polymorphism with metabolic syndrome in patients of coronary artery disease The subjects(60) will be the diagnosed cases of coronary artery disease and divided into two groups one with metabolic syndrome and the other without metabolic syndrome based on the National Cholestrol Education Program Adult Treatment Panel III definition

After informed consent 5 ml of venous blood sample will be collected in the plain vial 3ml and EDTA vial 2ml Serum SIRT1 level will be estimated by ELISA technique following the protocol as per manual The genotyping for PCSK9  gene polymorphism will be done using Allele Specific Oligonucleotide Polymerase chain reaction ASO PCR and RFLP

研究设计

研究类型
Observational

入排标准

年龄范围
40.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Cases of stable and unstable angina, and follow cases of myocardial infarction.

排除标准

  • All other cardiac disorders.

结局指标

主要结局

association of serum SIRT1 and metabolic syndrome in patients of coronary artery disease

时间窗: 4 weeks

次要结局

  • association between pcsk9 gene polymorphism & serum SIRT1 in patients of coronary artery disease with metabolic syndrome(4 weeks)

研究者

申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Anwar Pervez

Maulana Azad Medical college

研究点 (1)

Loading locations...

相似试验